Matches in Wikidata for { <http://www.wikidata.org/entity/Q80364328> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q80364328 description "clinical trial" @default.
- Q80364328 description "ensayu clínicu" @default.
- Q80364328 description "klinisch onderzoek" @default.
- Q80364328 description "клінічне випробування" @default.
- Q80364328 name "Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis" @default.
- Q80364328 name "Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis" @default.
- Q80364328 type Item @default.
- Q80364328 label "Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis" @default.
- Q80364328 label "Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis" @default.
- Q80364328 prefLabel "Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis" @default.
- Q80364328 prefLabel "Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis" @default.
- Q80364328 P1050 Q80364328-189F48E7-5071-4179-95D4-F1C5D2E1C6D9 @default.
- Q80364328 P1050 Q80364328-8F6DA34D-530E-4FEB-B5B3-8CA12CF9E270 @default.
- Q80364328 P1132 Q80364328-F153B5FA-3DC2-444C-8F89-A330FF903CE9 @default.
- Q80364328 P1476 Q80364328-C1B4B369-8708-4FAE-9227-1281238AEA57 @default.
- Q80364328 P2899 Q80364328-B4936288-8E5D-4392-B802-81AE6DD7A036 @default.
- Q80364328 P3098 Q80364328-CA7C49B6-60B2-403F-96B9-793831E4051F @default.
- Q80364328 P31 Q80364328-0C8B3414-C20A-4909-A0F7-89CEE35769C4 @default.
- Q80364328 P4844 Q80364328-865B34AD-8063-4043-8988-B21B85247505 @default.
- Q80364328 P580 Q80364328-60216BCB-189A-4C85-A086-4847D6D23359 @default.
- Q80364328 P582 Q80364328-AEA6F8FE-EB14-4176-9D0C-0E0E05101B84 @default.
- Q80364328 P6099 Q80364328-4C88125A-560E-4B60-8A83-85C9D6269C12 @default.
- Q80364328 P8363 Q80364328-68AD47BA-20D3-45CE-AF94-59A23C48152E @default.
- Q80364328 P921 Q80364328-2EBCF3FF-9984-4847-8238-583569B96793 @default.
- Q80364328 P1050 Q140067 @default.
- Q80364328 P1050 Q8277 @default.
- Q80364328 P1132 "+446" @default.
- Q80364328 P1476 "A Double-blind, Randomized, Placebo-controlled, Parallel-group Trial of the Efficacy and Safety of Nabiximols Oromucosal Spray as Add-on Therapy in Patients With Spasticity Due to Multiple Sclerosis" @default.
- Q80364328 P2899 "+18" @default.
- Q80364328 P3098 "NCT04203498" @default.
- Q80364328 P31 Q30612 @default.
- Q80364328 P4844 Q891968 @default.
- Q80364328 P580 "2020-03-01T00:00:00Z" @default.
- Q80364328 P582 "2021-09-01T00:00:00Z" @default.
- Q80364328 P6099 Q42824827 @default.
- Q80364328 P8363 Q78089383 @default.
- Q80364328 P921 Q55345908 @default.